Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
386 PX866, a derivative of wortmannin, was well tolerated in patients with recurrent mCRPC
As of 2026, the investigational drug Retatrutide remains in the advanced stages of clinical development, specifically within its comprehensive Phase 3 TRIUMPH program
Presented for research literature review only Sugimoto M (1995)
Methylenetetrahydrofolate reductase (MTHFR) is an enzyme that works as a catalyst for important biochemical reactions in your body
At the initiation dose of 2.5 mg weekly, a single 5 mL vial at 10 mg/mL provides 20 weeks of supply
( E ) Representative tracings showing LVDP recordings from isolated, perfused WT hearts treated with GLP-1(2836) or GLP-1 or with buffer only or scrambled(2836) (Scram) controls
US$ 24.68
US$ 25.36
US$ 25.16
US$ 28.82
